Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00424-010-0808-2, but it redirected us to https://link.springer.com/article/10.1007/s00424-010-0808-2. The analysis below is for the second page.

Title[redir]:
Nitric oxide and oxidative stress in vascular disease | Pflügers Archiv - European Journal of Physiology
Description:
Endothelium-derived nitric oxide (NO) is a paracrine factor that controls vascular tone, inhibits platelet function, prevents adhesion of leukocytes, and reduces proliferation of the intima. An enhanced inactivation and/or reduced synthesis of NO is seen in conjunction with risk factors for cardiovascular disease. This condition, referred to as endothelial dysfunction, can promote vasospasm, thrombosis, vascular inflammation, and proliferation of vascular smooth muscle cells. Vascular oxidative stress with an increased production of reactive oxygen species (ROS) contributes to mechanisms of vascular dysfunction. Oxidative stress is mainly caused by an imbalance between the activity of endogenous pro-oxidative enzymes (such as NADPH oxidase, xanthine oxidase, or the mitochondrial respiratory chain) and anti-oxidative enzymes (such as superoxide dismutase, glutathione peroxidase, heme oxygenase, thioredoxin peroxidase/peroxiredoxin, catalase, and paraoxonase) in favor of the former. Also, small molecular weight antioxidants may play a role in the defense against oxidative stress. Increased ROS concentrations reduce the amount of bioactive NO by chemical inactivation to form toxic peroxynitrite. Peroxynitrite—in turn—can “uncouple” endothelial NO synthase to become a dysfunctional superoxide-generating enzyme that contributes to vascular oxidative stress. Oxidative stress and endothelial dysfunction can promote atherogenesis. Therapeutically, drugs in clinical use such as ACE inhibitors, AT1 receptor blockers, and statins have pleiotropic actions that can improve endothelial function. Also, dietary polyphenolic antioxidants can reduce oxidative stress, whereas clinical trials with antioxidant vitamins C and E failed to show an improved cardiovascular outcome.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't figure out the monetization strategy.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, pubmed, cas, article, endothelial, nitric, oxide, synthase, vascular, circulation, hypertension, function, biol, dysfunction, disease, role, oxidative, stress, superoxide, tetrahydrobiopterin, cells, human, res, coronary, cardiovascular, expression, circ, forstermann, patients, activity, oxidase, production, clin, mice, nitricoxide, harrison, chem, nadph, atherosclerosis, physiol, acid, arginase, heart, angiotensin, arterioscler, thromb, vasc, increased, heme,

Topics {✒️}

oxidized low-density lipoprotein month download article/chapter hmg-coa reductase inhibitors endothelium-derived relaxing factor nitric oxide-mediated formation neuronal nitric-oxide synthase endothelial nitric-oxide synthase adverse long-term outcome nitric oxide-dependent vasodilatation nitric oxide/cgmp signaling s-adenosylmethionine-dependent methyltransferases c-src induces phosphorylation angiotensin ii-mediated hypertension ng-hydroxy-l-arginine angiotensin ii-induced hypertension nitric oxide/o2- imbalance reactive oxygen species insulin-resistant rat aorta dysfunctional superoxide-generating enzyme endothelium-dependent vasodilation ca2+/calmodulin-dependent formation cu/zn-superoxide dismutase endogenous pro-oxidative enzymes apolipoprotein e-deficient mice at1 receptor blockers at1 receptor blockade long-term vitamin nitric-oxide synthase nitric oxide synthase angiotensin-converting-enzyme inhibition endothelial nitric oxide full article pdf type angiotensin receptor l-arginine/asymmetric dimethylarginine restores endothelial function human endothelial cells nitric oxide synthases nitric-oxide synthases improve endothelial function nitric oxide synthesis vascular endothelial function coronary vasomotor response european economic area keaney jf jr privacy choices/manage cookies angiotensin ii infusion ca2+/calmodulin-dependent red wine increases atherosclerotic endothelial dysfunction endothelial superoxide production

Questions {❓}

  • Stocker R, Perrella MA (2006) Heme oxygenase-1: a novel drug target for atherosclerotic diseases?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Nitric oxide and oxidative stress in vascular disease
         description:Endothelium-derived nitric oxide (NO) is a paracrine factor that controls vascular tone, inhibits platelet function, prevents adhesion of leukocytes, and reduces proliferation of the intima. An enhanced inactivation and/or reduced synthesis of NO is seen in conjunction with risk factors for cardiovascular disease. This condition, referred to as endothelial dysfunction, can promote vasospasm, thrombosis, vascular inflammation, and proliferation of vascular smooth muscle cells. Vascular oxidative stress with an increased production of reactive oxygen species (ROS) contributes to mechanisms of vascular dysfunction. Oxidative stress is mainly caused by an imbalance between the activity of endogenous pro-oxidative enzymes (such as NADPH oxidase, xanthine oxidase, or the mitochondrial respiratory chain) and anti-oxidative enzymes (such as superoxide dismutase, glutathione peroxidase, heme oxygenase, thioredoxin peroxidase/peroxiredoxin, catalase, and paraoxonase) in favor of the former. Also, small molecular weight antioxidants may play a role in the defense against oxidative stress. Increased ROS concentrations reduce the amount of bioactive NO by chemical inactivation to form toxic peroxynitrite. Peroxynitrite—in turn—can “uncouple” endothelial NO synthase to become a dysfunctional superoxide-generating enzyme that contributes to vascular oxidative stress. Oxidative stress and endothelial dysfunction can promote atherogenesis. Therapeutically, drugs in clinical use such as ACE inhibitors, AT1 receptor blockers, and statins have pleiotropic actions that can improve endothelial function. Also, dietary polyphenolic antioxidants can reduce oxidative stress, whereas clinical trials with antioxidant vitamins C and E failed to show an improved cardiovascular outcome.
         datePublished:2010-03-21T00:00:00Z
         dateModified:2010-03-21T00:00:00Z
         pageStart:923
         pageEnd:939
         sameAs:https://doi.org/10.1007/s00424-010-0808-2
         keywords:
            Endothelial NO synthase
            Reactive oxygen species
            AT1 receptor antagonists
            ACE inhibitors
            Statins
            Vitamin C
            Vitamin E
            Polyphenols
            Human Physiology
            Molecular Medicine
            Neurosciences
            Cell Biology
            Receptors
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig5_HTML.gif
         isPartOf:
            name:Pflügers Archiv - European Journal of Physiology
            issn:
               1432-2013
               0031-6768
            volumeNumber:459
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ulrich Förstermann
               affiliation:
                     name:Johannes Gutenberg University Medical Center
                     address:
                        name:Department of Pharmacology, Johannes Gutenberg University Medical Center, Mainz, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Nitric oxide and oxidative stress in vascular disease
      description:Endothelium-derived nitric oxide (NO) is a paracrine factor that controls vascular tone, inhibits platelet function, prevents adhesion of leukocytes, and reduces proliferation of the intima. An enhanced inactivation and/or reduced synthesis of NO is seen in conjunction with risk factors for cardiovascular disease. This condition, referred to as endothelial dysfunction, can promote vasospasm, thrombosis, vascular inflammation, and proliferation of vascular smooth muscle cells. Vascular oxidative stress with an increased production of reactive oxygen species (ROS) contributes to mechanisms of vascular dysfunction. Oxidative stress is mainly caused by an imbalance between the activity of endogenous pro-oxidative enzymes (such as NADPH oxidase, xanthine oxidase, or the mitochondrial respiratory chain) and anti-oxidative enzymes (such as superoxide dismutase, glutathione peroxidase, heme oxygenase, thioredoxin peroxidase/peroxiredoxin, catalase, and paraoxonase) in favor of the former. Also, small molecular weight antioxidants may play a role in the defense against oxidative stress. Increased ROS concentrations reduce the amount of bioactive NO by chemical inactivation to form toxic peroxynitrite. Peroxynitrite—in turn—can “uncouple” endothelial NO synthase to become a dysfunctional superoxide-generating enzyme that contributes to vascular oxidative stress. Oxidative stress and endothelial dysfunction can promote atherogenesis. Therapeutically, drugs in clinical use such as ACE inhibitors, AT1 receptor blockers, and statins have pleiotropic actions that can improve endothelial function. Also, dietary polyphenolic antioxidants can reduce oxidative stress, whereas clinical trials with antioxidant vitamins C and E failed to show an improved cardiovascular outcome.
      datePublished:2010-03-21T00:00:00Z
      dateModified:2010-03-21T00:00:00Z
      pageStart:923
      pageEnd:939
      sameAs:https://doi.org/10.1007/s00424-010-0808-2
      keywords:
         Endothelial NO synthase
         Reactive oxygen species
         AT1 receptor antagonists
         ACE inhibitors
         Statins
         Vitamin C
         Vitamin E
         Polyphenols
         Human Physiology
         Molecular Medicine
         Neurosciences
         Cell Biology
         Receptors
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00424-010-0808-2/MediaObjects/424_2010_808_Fig5_HTML.gif
      isPartOf:
         name:Pflügers Archiv - European Journal of Physiology
         issn:
            1432-2013
            0031-6768
         volumeNumber:459
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ulrich Förstermann
            affiliation:
                  name:Johannes Gutenberg University Medical Center
                  address:
                     name:Department of Pharmacology, Johannes Gutenberg University Medical Center, Mainz, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Pflügers Archiv - European Journal of Physiology
      issn:
         1432-2013
         0031-6768
      volumeNumber:459
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Johannes Gutenberg University Medical Center
      address:
         name:Department of Pharmacology, Johannes Gutenberg University Medical Center, Mainz, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ulrich Förstermann
      affiliation:
            name:Johannes Gutenberg University Medical Center
            address:
               name:Department of Pharmacology, Johannes Gutenberg University Medical Center, Mainz, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology, Johannes Gutenberg University Medical Center, Mainz, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(540)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

5s.